BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 26497054)

  • 1. Change of treatment guidelines and evolution of ART initiation in rural South Africa: data of a large HIV care and treatment programme.
    Plazy M; Dabis F; Naidu K; Orne-Gliemann J; Barnighausen T; Dray-Spira R
    BMC Infect Dis; 2015 Oct; 15():452. PubMed ID: 26497054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors associated with antiretroviral treatment initiation amongst HIV-positive individuals linked to care within a universal test and treat programme: early findings of the ANRS 12249 TasP trial in rural South Africa.
    Boyer S; Iwuji C; Gosset A; Protopopescu C; Okesola N; Plazy M; Spire B; Orne-Gliemann J; McGrath N; Pillay D; Dabis F; Larmarange J;
    AIDS Care; 2016; 28 Suppl 3(Suppl 3):39-51. PubMed ID: 27421051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Barriers to antiretroviral treatment initiation in rural KwaZulu-Natal, South Africa.
    Plazy M; Newell ML; Orne-Gliemann J; Naidu K; Dabis F; Dray-Spira R
    HIV Med; 2015 Oct; 16(9):521-32. PubMed ID: 25857535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment guidelines and early loss from care for people living with HIV in Cape Town, South Africa: A retrospective cohort study.
    Katz IT; Kaplan R; Fitzmaurice G; Leone D; Bangsberg DR; Bekker LG; Orrell C
    PLoS Med; 2017 Nov; 14(11):e1002434. PubMed ID: 29136014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of "test and treat" recommendations on eligibility for antiretroviral treatment: Cross sectional population survey data from three high HIV prevalence countries.
    Chihana ML; Huerga H; Van Cutsem G; Ellman T; Wanjala S; Masiku C; Szumilin E; Etard JF; Davies MA; Maman D
    PLoS One; 2018; 13(11):e0207656. PubMed ID: 30475865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Continuum in HIV care from entry to ART initiation in rural KwaZulu-Natal, South Africa.
    Plazy M; Dray-Spira R; Orne-Gliemann J; Dabis F; Newell ML
    Trop Med Int Health; 2014 Jun; 19(6):680-689. PubMed ID: 24654990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of early antiretroviral therapy eligibility on HIV acquisition: household-level evidence from rural South Africa.
    Oldenburg CE; Bor J; Harling G; Tanser F; Mutevedzi T; Shahmanesh M; Seage GR; De Gruttola V; Mimiaga MJ; Mayer KH; Pillay D; Bärnighausen T
    AIDS; 2018 Mar; 32(5):635-643. PubMed ID: 29334546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trends in and correlates of CD4+ cell count at antiretroviral therapy initiation after changes in national ART guidelines in Rwanda.
    Mutimura E; Addison D; Anastos K; Hoover D; Dusingize JC; Karenzie B; Izimukwiye I; Mutesa L; Nsanzimana S; Nash D;
    AIDS; 2015 Jan; 29(1):67-76. PubMed ID: 25562492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uptake of antiretroviral therapy and male circumcision after community-based HIV testing and strategies for linkage to care versus standard clinic referral: a multisite, open-label, randomised controlled trial in South Africa and Uganda.
    Barnabas RV; van Rooyen H; Tumwesigye E; Brantley J; Baeten JM; van Heerden A; Turyamureeba B; Joseph P; Krows M; Thomas KK; Schaafsma TT; Hughes JP; Celum C
    Lancet HIV; 2016 May; 3(5):e212-20. PubMed ID: 27126488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of nurse-delivered community-based CD4 services on facilitating pre-ART care in rural South Africa.
    Kompala T; Moll AP; Mtungwa N; Brooks RP; Friedland GH; Shenoi SV
    BMC Health Serv Res; 2016 Aug; 16(a):374. PubMed ID: 27515233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Failure to initiate HIV treatment in patients with high CD4 counts: evidence from demographic surveillance in rural South Africa.
    Bor J; Chiu C; Ahmed S; Katz I; Fox MP; Rosen S; Yapa M; Tanser F; Pillay D; Bärnighausen T
    Trop Med Int Health; 2018 Feb; 23(2):206-220. PubMed ID: 29160949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Do HIV treatment eligibility expansions crowd out the sickest? Evidence from rural South Africa.
    Kluberg SA; Fox MP; LaValley M; Pillay D; Bärnighausen T; Bor J
    Trop Med Int Health; 2018 Sep; 23(9):968-979. PubMed ID: 29947442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment eligibility and retention in clinical HIV care: A regression discontinuity study in South Africa.
    Bor J; Fox MP; Rosen S; Venkataramani A; Tanser F; Pillay D; Bärnighausen T
    PLoS Med; 2017 Nov; 14(11):e1002463. PubMed ID: 29182641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Timing and Predictors of Initiation on Antiretroviral Therapy Among Newly-Diagnosed HIV-Infected Persons in South Africa.
    Larsen A; Cheyip M; Tesfay A; Vranken P; Fomundam H; Wutoh A; Aynalem G
    AIDS Behav; 2019 Feb; 23(2):375-385. PubMed ID: 30008050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Universal test and treat is not associated with sub-optimal antiretroviral therapy adherence in rural South Africa: the ANRS 12249 TasP trial.
    Iwuji C; McGrath N; Calmy A; Dabis F; Pillay D; Newell ML; Baisley K; Porter K
    J Int AIDS Soc; 2018 Jun; 21(6):e25112. PubMed ID: 29890048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Age in antiretroviral therapy programmes in South Africa: a retrospective, multicentre, observational cohort study.
    Cornell M; Johnson LF; Schomaker M; Tanser F; Maskew M; Wood R; Prozesky H; Giddy J; Stinson K; Egger M; Boulle A; Myer L;
    Lancet HIV; 2015 Sep; 2(9):e368-75. PubMed ID: 26423550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the impact of immediate versus WHO recommendations-guided antiretroviral therapy initiation on HIV incidence: the ANRS 12249 TasP (Treatment as Prevention) trial in Hlabisa sub-district, KwaZulu-Natal, South Africa: study protocol for a cluster randomised controlled trial.
    Iwuji CC; Orne-Gliemann J; Tanser F; Boyer S; Lessells RJ; Lert F; Imrie J; Bärnighausen T; Rekacewicz C; Bazin B; Newell ML; Dabis F;
    Trials; 2013 Jul; 14():230. PubMed ID: 23880306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Time to eligibility for antiretroviral therapy in adults with CD4 cell count > 500 cells/μL in rural KwaZulu-Natal, South Africa.
    McGrath N; Lessells RJ; Newell ML
    HIV Med; 2015 Sep; 16(8):512-8. PubMed ID: 25959724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of eliminating CD4-count thresholds on HIV treatment initiation in South Africa: An empirical modeling study.
    Bor J; Ahmed S; Fox MP; Rosen S; Meyer-Rath G; Katz IT; Tanser F; Pillay D; Bärnighausen T
    PLoS One; 2017; 12(6):e0178249. PubMed ID: 28617805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implementing universal HIV treatment in a high HIV prevalence and rural South African setting - Field experiences and recommendations of health care providers.
    Plazy M; Perriat D; Gumede D; Boyer S; Pillay D; Dabis F; Seeley J; Orne-Gliemann J
    PLoS One; 2017; 12(11):e0186883. PubMed ID: 29155832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.